Oncology nurses play essential roles in the emerging field of cardio-oncology, which aims to protect patients’ heart function ...

CD19-targeted CAR T cells have transformed the management of patients with relapsed and/or refractory large B cell lymphoma, and these therapies are increasingly being administered as earlier-line ...

It has been reported that serum CA125 is correlated with the prognosis of non-Hodgkin’s lymphoma. The objective of this study is to explore the clinical value of CA125 in diffuse large B-cell lymphoma ...

The specific treatment course and prognosis for T-cell lymphoma depends on the subtype — of which there are many — and how advanced the cancer is. Hodgkin lymphoma involves a type of cancer ...

The presence of a single disease allele in related, but clinically distinct MPD indicates that additional genetic events contribute to the pathogenesis of these disorders. The discovery of ...

2,6 Further analysis to determine DLBCL pathogenesis and subtype includes an immunohistochemistry ... as this is used to determine whether disease is nonbulky or bulky. Bulky lymphoma is defined as ...

5 Approximately 15% to 25% of patients who have PCNSL present with ocular involvement—primary vitreoretinal lymphoma (PVRL). Monocular symptoms may occur more frequently at disease onset, but ...

Up to one-third of all people with non-Hodgkin's lymphoma have diffuse large B-cell lymphoma (DLBCL). DLBCL grows quickly, but it's possible to cure it. Most people learn they have this type after ...

Evidence that smoking causes non-Hodgkin’s lymphoma is mixed. However, smoking might create molecules that could prevent the destruction of cancerous cells. In general, smoking increases the ...